These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 18006786)
21. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
22. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733 [TBL] [Abstract][Full Text] [Related]
23. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Bean GR; Scott V; Yee L; Ratliff-Daniel B; Troch MM; Seo P; Bowie ML; Marcom PK; Slade J; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Baker JC; Wilke LG; Seewaldt VL Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):790-8. PubMed ID: 15824145 [TBL] [Abstract][Full Text] [Related]
24. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956 [TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis. Ota N; Kawakami K; Okuda T; Takehara A; Hiranuma C; Oyama K; Ota Y; Oda M; Watanabe G Anticancer Res; 2006; 26(5B):3729-32. PubMed ID: 17094392 [TBL] [Abstract][Full Text] [Related]
27. Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Liu T; Niu Y; Feng Y; Niu R; Yu Y; Lv A; Yang Y Hum Pathol; 2008 Nov; 39(11):1637-46. PubMed ID: 18657295 [TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542 [TBL] [Abstract][Full Text] [Related]
29. Methylation of the INK4A/ARF locus in blood mononuclear cells. Deligezer U; Erten N; Akisik EE; Dalay N Ann Hematol; 2006 Feb; 85(2):102-7. PubMed ID: 16320052 [TBL] [Abstract][Full Text] [Related]
30. Homozygous deletions of the INK4a/ARF locus in renal cell cancer. Kasahara T; Bilim V; Hara N; Takahashi K; Tomita Y Anticancer Res; 2006; 26(6B):4299-305. PubMed ID: 17201148 [TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression. van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902 [TBL] [Abstract][Full Text] [Related]
32. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Brenner AJ; Stampfer MR; Aldaz CM Oncogene; 1998 Jul; 17(2):199-205. PubMed ID: 9674704 [TBL] [Abstract][Full Text] [Related]
33. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780 [TBL] [Abstract][Full Text] [Related]
34. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319 [TBL] [Abstract][Full Text] [Related]
35. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Calmon MF; Colombo J; Carvalho F; Souza FP; Filho JF; Fukuyama EE; Camargo AA; Caballero OL; Tajara EH; Cordeiro JA; Rahal P Cancer Genet Cytogenet; 2007 Feb; 173(1):31-7. PubMed ID: 17284367 [TBL] [Abstract][Full Text] [Related]
36. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis]. Chen M; Cui PG; Yao X; Cao YH; Gong JQ; Li AS; Chen ZQ Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):674-6. PubMed ID: 18067081 [TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Papadimitrakopoulou VA; Izzo J; Mao L; Keck J; Hamilton D; Shin DM; El-Naggar A; den Hollander P; Liu D; Hittelman WN; Hong WK Clin Cancer Res; 2001 Oct; 7(10):3127-34. PubMed ID: 11595705 [TBL] [Abstract][Full Text] [Related]
38. Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors. Yin D; Xie D; Hofmann WK; Miller CW; Black KL; Koeffler HP Oncogene; 2002 Nov; 21(54):8372-8. PubMed ID: 12447702 [TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome. Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076 [TBL] [Abstract][Full Text] [Related]
40. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Murao K; Kubo Y; Ohtani N; Hara E; Arase S Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]